Associated Papers
A novel loss of function mutation in the HAVCR2 gene in a patient diagnosed with Hodgkin's lymphoma.
Erdem S et al.
Immunologic Research, 2025
Characteristics and therapeutic outcomes of subcutaneous panniculitis-like T-cell lymphoma with and without germline HAVCR2 mutations in Thai children and adolescents.
Youthong P et al.
Orphanet Journal of Rare Diseases, 2024
Genetic profiles and clinical features in subcutaneous panniculitis-like T-cell lymphomas.
Okamura Y et al.
Cancer Science, 2024
An investigation of germline variants of HAVCR2 in subcutaneous panniculitis-like T-cell lymphoma and related lesions in a North American population.
Cheng J et al.
Haematologica, 2024
Therapeutic efficacy of allogenic haematopoietic stem cell transplantation from an appropriate sibling donor to a patient with subcutaneous panniculitis-like T-cell lymphoma with a germline homozygous HAVCR2 mutation.
Morisaka H et al.
Journal of the European Academy of Dermatology and Venereology : Jeadv, 2024
Pediatric lymphoproliferative disorders associated with inborn errors of immunity.
Cheng J et al.
Clinical Immunology (orlando, Fla.), 2024
Genomic Landscape of Susceptibility to Severe COVID-19 in the Slovenian Population.
Kovanda A et al.
International Journal of Molecular Sciences, 2024
Germline HAVCR2/TIM-3 Checkpoint Inhibitor Receptor Deficiency in Recurrent Autoinflammatory Myocarditis.
Pernaa N et al.
Journal of Clinical Immunology, 2024
Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency.
Baldrich A et al.
Journal of Clinical Immunology, 2024
Subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic lymphohistiocytosis: a systematic review of 63 patients reported in the literature.
Ou W et al.
Clinical and Experimental Medicine, 2023
Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis.
Moonla C et al.
Haematologica, 2023
Rare genetic variants involved in multisystem inflammatory syndrome in children: a multicenter Brazilian cohort study.
Reis BCSD et al.
Frontiers in Cellular and Infection Microbiology, 2023
Routine Diagnostics Confirm Novel Neurodevelopmental Disorders.
Jauss RT et al.
Genes, 2022
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.
Langenberg KPS et al.
European Journal of Cancer (oxford, England : 1990), 2022
Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas.
Gallardo F et al.
Cancers, 2022
Identification of variants in genes associated with autoinflammatory disorders in a cohort of patients with psoriatic arthritis.
Atschekzei F et al.
Rmd Open, 2022
Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression.
Tromp SAM et al.
Blood Advances, 2022
Presence of rare potential pathogenic variants in subjects under 65 years old with very severe or fatal COVID-19.
López-Rodríguez R et al.
Scientific Reports, 2022
A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling.
Zhang Y et al.
Frontiers in Oncology, 2022
Advances in the understanding and treatment of Cutaneous T-cell Lymphoma.
Bakr FS et al.
Frontiers in Oncology, 2022
Subcutaneous panniculitis-like T-cell lymphomas with homozygous inheritance of HAVCR2 mutations in Vietnamese pedigrees.
Nguyen MC et al.
Pediatric Blood & Cancer, 2021
Subcutaneous panniculitis-like T-cell lymphoma in a 14-year-old female homozygous for HAVCR2 mutation.
Frederiks AJ et al.
The Australasian Journal of Dermatology, 2021
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations.
Koh J et al.
Blood Advances, 2021
Subcutaneous Panniculitis-like T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis Syndrome in Children and Its Essential Role of HAVCR2 Gene Mutation Analysis.
Chaweephisal P et al.
Journal of Pediatric Hematology/oncology, 2021
TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis.
Wegehaupt O et al.
Pediatric Blood & Cancer, 2020
TIM3 comes of age as an inhibitory receptor.
Wolf Y et al.
Nature Reviews. Immunology, 2020
Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Gayden T et al.
Nature Genetics, 2019
Publisher Correction: Cancer genetics, precision prevention and a call to action.
Turnbull C et al.
Nature Genetics, 2019
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Gayden T et al.
Nature Genetics, 2018
Human disease mutations highlight the inhibitory function of TIM-3.
Dixon KO et al.
Nature Genetics, 2018
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X et al.
Nucleic Acids Research, 2014
T-cell immunoglobulin and mucin domain 3 genetic polymorphisms are associated with rheumatoid arthritis independent of a shared epitope status.
Song YW et al.
Human Immunology, 2011
Good prognosis of adult hemophagocytic lymphohistiocytosis associated with the germline HAVCR2 mutation.
Boonyabaramee P et al.
Experimental Hematology, 0
Pediatric Cutaneous T-Cell Neoplasms: Clinical and Pathological Features, Updated Classifications, and Critical Differential Diagnoses.
Cheng J et al.
Pediatric Dermatology, 0